Correlation Between GenMont Biotech and Sinphar Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both GenMont Biotech and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GenMont Biotech and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GenMont Biotech and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on GenMont Biotech and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GenMont Biotech with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of GenMont Biotech and Sinphar Pharmaceutical.
Diversification Opportunities for GenMont Biotech and Sinphar Pharmaceutical
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GenMont and Sinphar is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding GenMont Biotech and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and GenMont Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GenMont Biotech are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of GenMont Biotech i.e., GenMont Biotech and Sinphar Pharmaceutical go up and down completely randomly.
Pair Corralation between GenMont Biotech and Sinphar Pharmaceutical
Assuming the 90 days trading horizon GenMont Biotech is expected to under-perform the Sinphar Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, GenMont Biotech is 1.15 times less risky than Sinphar Pharmaceutical. The stock trades about -0.02 of its potential returns per unit of risk. The Sinphar Pharmaceutical Co is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 3,080 in Sinphar Pharmaceutical Co on August 25, 2024 and sell it today you would earn a total of 35.00 from holding Sinphar Pharmaceutical Co or generate 1.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GenMont Biotech vs. Sinphar Pharmaceutical Co
Performance |
| Timeline |
| GenMont Biotech |
| Sinphar Pharmaceutical |
GenMont Biotech and Sinphar Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GenMont Biotech and Sinphar Pharmaceutical
The main advantage of trading using opposite GenMont Biotech and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GenMont Biotech position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.| GenMont Biotech vs. Voltronic Power Technology | GenMont Biotech vs. Galaxy Software Services | GenMont Biotech vs. Sunnic Technology Merchandise | GenMont Biotech vs. Golden Biotechnology |
| Sinphar Pharmaceutical vs. CHC Healthcare Group | Sinphar Pharmaceutical vs. GenMont Biotech | Sinphar Pharmaceutical vs. Abnova Taiwan Corp | Sinphar Pharmaceutical vs. Wellell |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |